Safety and Efficacy Study of ATGC-100 for the Treatment of Moderate to Severe Glabellar Lines in Adult Subjects
Clinical trial NCT03970876 · COMPLETED
Trial details
- NCT number
- NCT03970876
- Sponsor
- EuBiologics Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-19
- Primary completion
- 2019-09-11
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.